Guideline
Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - European Society for Medical Oncology (ESMO)
Hairy cell leukaemia accounts for 2% of adult leukaemia, and occurs more often in men than in women. The new ESMO Clinical Practice Guidelines provide up-to-date information on the management of hairy cell leukaemia, including recommendations for diagnosis and staging, as well as detailed treatment sections referring to the latest studies and reviews.